Clinical trial
Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of…
NCT00313950 · Sanofi Pasteur, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00313950 |
|---|---|
| Title | Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine |
| Official title | Immunogenicity and Safety of AVAXIM™ 80U-Pediatric Administered Alone or Concomitantly With TRIMOVAX™ in 12-13 Months Old Healthy Hepatitis A Seronegative Turkish Children |
| Lead sponsor | Sanofi Pasteur, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Measles, Mumps, Rubella, Hepatitis A |
| Intervention type | Biological |
| Interventions | Inactivated Hep A vaccine, Attenuated Measles Mumps Rubella |
| Enrollment | 470 |
| Start date | Sep 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Apr 1, 2010 |
| First posted | Apr 12, 2006 |
| Last update posted | Jan 22, 2014 |
| Countries | Turkey (Türkiye) |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: